Good news in the health-care arena

First – if you haven’t heard, yet – 10 of the world’s top-selling drugs are going “off-patent” in the next year or so, which is expected to save American consumers and insurance companies quite a bit of money.

Prices on some top drugs could go down by as much as 80 percent. Industry experts are expecting to see about $1 billion in savings next year for consumers who take the cholesterol-fighting drug Lipitor.

That’s no small feat, given that Lipitor is the best-selling drug ever, accounting for $106 billion in sales over the last decade. New York-based Pfizer Inc. (NYSE:PFE) recorded…